Pfizer Inc. [NYSE: PFE] gained 0.76% on the last trading session, reaching $27.76 price per share at the time. The company report on February 19, 2024 at 7:45 AM that European Commission Approves Pfizer’s VELSIPITY® for Patients with Moderately to Severely Active Ulcerative Colitis. VELSIPITY
Pfizer Inc. [NYSE: PFE] jumped around 0.11 points on Friday, while shares priced at $27.62 at the close of the session, up 0.40%. The company report on February 19, 2024 at 7:45 AM that European Commission Approves Pfizer’s VELSIPITY® for Patients with Moderately to Severely
Pfizer Inc. [NYSE: PFE] gained 27.56% or -32.62 points to close at $27.57 with a heavy trading volume of 46.35M shares. The company report on February 6, 2024 at 6:45 AM that Arvinas and Pfizer’s Vepdegestrant (ARV-471) Receives FDA Fast Track Designation for the Treatment
Pfizer Inc. [NYSE: PFE] plunged by -$0.36 during the normal trading session on while it closed the day at $26.93. The company report on February 2, 2024 at 6:45 AM that Tisotumab Vedotin Marketing Authorization Application Validated by European Medicines Agency for Treatment of Recurrent
Pfizer Inc. [NYSE: PFE] slipped around 0.0 points on Friday, while shares priced at $27.47 at the close of the session, down 0.00%. The company report on January 26, 2024 at 12:00 PM that European Medicines Agency Validates Type II Variation Application for PADCEV® (enfortumab
In the oil sector, in the expectation of an economic rebound in 2021 thanks to anti-Covid-19 vaccinations, optimism has continued to increase costs. In the January Nymex contract, U.S. light crude oil (WTI) rose 0.9 percent to $46.99 a barrel. In February, the Brent contract
The arrangements for coronavirus vaccine programs are well underway on the health front. On Tuesday, the UK distinguished itself by being the first country in the world to approve the use of American Pfizer and its German partner BioNTech’s Covid-19 vaccine. The vaccine will be
On the back of growing market operation and the results of testing another vaccine, our indexes rose Key-U.S. indices closed in the green zone on Monday, November 23. The market was supported by statements by the British pharmaceutical company AstraZeneca on the potential 90 percent
© 2024, Powered by Smart TechOne
